Clinical Study Finds Breast PET Imaging an Effective Tool in Pre-surgical Planning

Share Article

An initial clinical evaluation at The Center for Advanced Breast Care in Arlington Heights, IL, points to the CMR Naviscan Breast PET technology as a powerful tool in managing care for its patients. Due to the high specificity and low false positive rate findings in the initial evaluation, Breast PET Imaging demonstrates its ability to play a crucial role in the pre-surgical assessment of the axil la in patients diagnosed with breast cancer.

An initial clinical evaluation at The Center for Advanced Breast Care in Arlington Heights, IL, points to the CMR Naviscan Breast PET technology as a powerful tool in managing care for its patients. Due to the high specificity and low false positive rate findings in the initial evaluation, Breast PET Imaging demonstrates its ability to play a crucial role in the pre-surgical assessment of the axil la in patients diagnosed with breast cancer.

The retrospective analysis of results in 130 patients, yielded a false positive rate of 1%. Dr. Michael Kinney, Center Director and lead author of the study, states "that High Resolution Breast PET imaging enhances patient care by identifying the extent of disease in the breast and axilla."

Clinical evaluation of the axilla is an area of increasing interest in managing breast cancer. Axillary lymph node status is a critical prognostic indicator. Physical exam has proven to be inadequate with some studies demonstrating error rates as high as 41% and false positives rates as high as 53%. Axillary evaluation with ultrasound has shown discrepant results in the sensitivity, specificity and predictive value of the method. Breast MRI is another modality that can be used, however it has a high false positive rate, potential allergic reactions, possible kidney complications, and cannot be used in patients with claustrophobia or metal implants.

Metabolic information provided by high resolution Breast PET Imaging effectively provides major guidance in the preoperative investigation, to facilitate decisions regarding the inclusion of neoadjuvant chemotherapy and the appropriate use of sentinel lymph node biopsy (SLNB) and/or axillary lymph node dissection (ALND).

For a full copy of the clinical study white paper go to: http://advancedbreastcare.net/white-paper-pet.pdf

About The Center for Advanced Breast Care

The Center for Advanced Breast Care was the first medical practice in Chicago's northwest suburbs that devoted itself exclusively to the diagnosis, treatment and prevention of breast disease. Women with breast problems deserve to have every possible option presented to them for their evaluation and treatment. Breast Pet Imaging significantly enhances our comprehensive and advanced breast care.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sue Griffin, RN
Visit website